5 Best Performing Biotech Stocks in 2023

3. Tempest Therapeutics, Inc. (NASDAQ:TPST)

Year To Date Share Price Gains: 387.81%

Tempest Therapeutics, Inc. (NASDAQ:TPST) is a small biotechnology firm with a novel approach to cancer treatments that sees it combine immune system responses and broader cancer treatments. Its shares are rated Strong Buy on average, and the firm has beaten analyst EPS estimates in three of its four latest quarters even though it is yet to turn a profit.

By the end of this year’s second quarter, six out of the 910 hedge funds polled by Insider Monkey had held a stake in Tempest Therapeutics, Inc. (NASDAQ:TPST).

Follow Tempest Therapeutics Inc. (NASDAQ:TPST)